A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PBZ / phenylbutazone

[Related PubMed/MEDLINE]
Total Number of Papers: 105
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PBZ  (>> Co-occurring Abbreviation)
Long Form:   phenylbutazone
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Enhanced abatement of pharmaceuticals by permanganate via the addition of Co3O4 nanoparticles. NPs, SPZ
2020 Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses. FM
2018 Intermolecular interactions determined by NOE build-up in macromolecules from hyperpolarized small molecules. D-DNP, NOE
2018 Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses. ---
2017 Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse. BW, HBS, MXM, NSAID, SYN
2017 The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS. MS, OXPBZ
2016 Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS. OXPBZ, SPE
2016 Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses. MCBL
2016 Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy. NSAID
10  2015 Phenylbutazone Oxidation via Cu,Zn-SOD Peroxidase Activity: An EPR Study. Cu,Zn-SOD, DMPO, EPR
11  2015 The Safety and Pharmacokinetics of Carprofen, Flunixin and Phenylbutazone in the Cape Vulture (Gyps coprotheres) following Oral Exposure. CRP, FXN
12  2014 In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis. GAG, LPS, MMP, SF
13  2014 Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa. MPO, NSAIDs, PGE2
14  2014 Phenylbutazone and ketoprofen binding to serum albumin. Fluorescence study. KP, RA
15  2013 Is phenylbutazone a genotoxic carcinogen? A weight-of-evidence assessment. WoE
16  2012 Effects of meloxicam and phenylbutazone on equine gastric mucosal permeability. ---
17  2012 PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern. Ala, EDA, MD, PAMAM, PMF, Prim, SAL
18  2011 A spectroscopic study of phenylbutazone and aspirin bound to serum albumin in rheumatoid diseases. aI, RDs, SA
19  2011 Competitive binding to plasma thyroid hormone transport proteins and thyroid disruption by phenylbutazone used as a probe. TH
20  2011 Development and validation of a confirmatory method for the determination of 12 non steroidal anti-inflammatory drugs in milk using liquid chromatography-tandem mass spectrometry. CPF, DC, FLU, KTP, MF, MLX, NP, NSAIDs, OPB, TLF, VDP
21  2011 Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses. FM, LS, NSAIDs, SAL
22  2011 Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. FM, HR, LS, NSAID, SAL
23  2011 The use of phenylbutazone in the horse. NSAID
24  2010 Association of phenylbutazone usage with horses bought for slaughter: a public health risk. NSAID, TB
25  2010 Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control. DMX, DT
26  2009 Determination of ibuprofen, ketoprofen, diclofenac and phenylbutazone in bovine milk by gas chromatography-tandem mass spectrometry. DCF, IBP, KPF
27  2009 Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses. SBZ
28  2009 Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. MSA
29  2009 Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses. SBZ
30  2009 Rapid confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by rapid resolution liquid chromatography tandem mass spectrometry. CPF, DCF, MFN, NAP, NIFLU, OXYPHEN, SUXI
31  2008 Anti-inflammatory activity of indanyltetrazole derivatives. BIMT, BIT, CIMT, CIT
32  2008 Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse. HR, LS, PCV, SAL
33  2006 Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. NSAIDs
34  2006 Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals. ---
35  2005 Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation. BK, DL, PGE2
36  2005 Interleukin-1beta inhibits paw oedema induced by local administration of latex of Calotropis procera extracts. DEX, IL-1beta, MeDL
37  2004 Antinociceptive and anti-inflammatory effects of Dorstenia barteri (Moraceae) leaf and twig extracts in mice. ASA
38  2004 Effect of anti-inflammatory drugs on pleurisy induced by latex of Calotropis procera in rats. DL, PGs
39  2003 Effects of lipopolysaccharide and phenylbutazone on gastric contents in the horse. LPS
40  2003 Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. SBZ
41  2002 Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes. COX, DEX, PGE2, reIL-1beta
42  2002 In vitro anion transport alterations and apoptosis induced by phenylbutazone in the right dorsal colon of ponies. PGE2, RDC
43  2002 Inducible nitric oxide expression in equine articular chondrocytes: effects of antiinflammatory compounds. DEX, HA, iNOS, PSGAG, reIL-1beta
44  2002 Pharmacodynamics and pharmacokinetics of phenylbutazone in calves. COX, i.v, LTB4, OPBZ, PGE2, TXB2
45  2001 Anti-diarrhoeal activity of the latex of Calotropis procera. DL
46  2001 Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants. CRP, DMSO, FNX, KET, LPS, MEL, METH, PGE2
47  2000 Effects of phenylbutazone on bone activity and formation in horses. MAR
48  1999 Disposition and tolerance of suxibuzone in horses. i.v, MRT, OPBZ, SBZ
49  1999 Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses. OPBZ, SBZ
50  1998 Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. FM, LTB4, PG, WBC
51  1998 Species differences of serum albumins: I. Drug binding sites. DZ, IP, WF
52  1998 Stereoselective binding of ketoprofen enantiomers to human serum albumin studied by high-performance liquid affinity chromatography. DAZ, HSA
53  1997 Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonamides on hepatic cytochrome P4502C activity in vitro, and correlation with some molecular descriptors in the dwarf goat (Caprus hircus aegagrus). DF, PT
54  1997 Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery. TPPSI
55  1997 The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse. APR, DMS
56  1996 Determination of phenylbutazone residues in bovine milk by liquid chromatography with UV detection. LC, RSDs
57  1996 Quantification of phenylbutazone in equine sera by use of high-performance liquid chromatography with a nonevaporative extraction technique. HPLC, OXY
58  1996 The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses. OPBZ
59  1995 A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. i.v, IM
60  1995 Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration. OPBZ
61  1994 Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. FM, PK/PD
62  1993 Modulation of bronchial responsiveness in horses by phenylbutazone and furosemide. FUR
63  1993 Pharmacokinetics of phenylbutazone in neonatal foals. ---
64  1993 The disposition of suxibuzone in the horse. i.v, OPBZ, SXB
65  1993 The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats. gamma-OHPBZ, OPBZ, Vd
66  1993 The intramuscular bioavailability of a phenylbutazone preparation in the horse. i.v, IM, OHPBZ, OPBZ
67  1990 Age-dependent pharmacokinetics of phenylbutazone in calves. ---
68  1990 Mechanism of pharmacodynamic and pharmacokinetic interactions between acetohexamide and phenylbutazone in rabbits. AH, CLNR, CLR
69  1990 Modulation of an adhesion-related surface antigen on equine neutrophils by bacterial lipopolysaccharide and antiinflammatory drugs. DEX, LeuCAMs, LPS, MoAb 60.3, PMA, ZAS
70  1990 Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls. ---
71  1990 Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing. ---
72  1989 Effect of phenylbutazone on serum protein binding and pharmacokinetic behavior of sulfadimethoxine in rabbits, dogs and rats. N4-AcSDM, SDM
73  1989 Sex differences in nephrotoxic and gastrointestinal effects of phenylbutazone. BUN, MDA, PAH
74  1989 Synthesis and pharmacological activity of imidazolyn-5-ones. ---
75  1989 The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. BW
76  1988 Horse pill ("bute") hemorrhage. NSAID
77  1987 Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. OPBZ, U/P
78  1987 The effects of phenylbutazone on acetylcholine-initiated contractions of gastric muscularis muscle of Bufo marinus. ACh, PG, PGE2
79  1986 Concentration of phenylbutazone (PBZ) and 13, 14-dihydro-15 keto PGF(2alpha) (PGFM) in blood and seminal plasma of stallions treated with PBZ. SP
80  1986 Effect of phenylbutazone on serum protein binding of sulfadimethoxine in different animal species. N4-AcSDM, SDM
81  1986 Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation. ---
82  1985 Effect of phenylbutazone (PBZ) on luteolysis in the mare induced by uterine biopsy. ---
83  1985 Efficacy of testing for illegal medication in horses. ---
84  1985 Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2. ---
85  1985 Inhibition of prostaglandin biosynthesis by a new anti-inflammatory drug, TA-60. IM, IP, NSAIDs, PG
86  1985 Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens. ---
87  1985 Possible involvement of non-steroidal anti-inflammatory drugs in vagal-mediated gastric acid secretion in rats. 2dG, FA, FP, i.c.v, IM, IP, NSAIDs, PG, PGs, RWIS
88  1984 Effect of lysine-acetylsalicylate and phenylbutazone premedication on the protein content of secondary aqueous humour in the dog. LAS
89  1984 Genetic and histological aspects of stomach lesions induced by systemic injection of phenylbutazone in the rat. FD
90  1984 Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudate. NSAID, PGE2, TXB2
91  1983 Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration. EH
92  1982 Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone. fMLP, PMNs
93  1982 Effect of some enzyme inducers, fluids, and methionine-thiosulfate on induced acute aflatoxicosis in goats. AFB1, MET-TS, PB, PRO
94  1982 Prevention of phenylbutazone ulcer in the rat by glucose: role of a glycoprivic receptor system. ---
95  1982 Toxicologic study of carboxyatractyloside (active principle in cocklebur--Xanthium strumarium) in rats treated with enzyme inducers and inhibitors and glutathione precursor and depletor. BNF, CAT, Cys, EM, PB, PBO
96  1981 Chemotactic deactivation of human neutrophils: protective influence of phenylbutazone. F-Met-Phe
97  1981 Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. ---
98  1981 Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies. ---
99  1979 Prostaglandins, rheumatoid arthritis, fibrin and lymphoedema. EV, INDO, NSAIDs
100  1977 Bioavailability evaluation of an enteric-coated phenylbutazone formulation, and cross-over comparison with a sugar-coated product. ---